aspen
Mylan reaches agreement with Aspen for their European thrombosis business
September 8, 2020Manufacturing and Production Mylan, aspen
Mylan has announced an agreement to acquire the intellectual property and commercialisation rights to Aspen’s thrombosis business for €641.9 million. …
South Africa’s over-charging case against Aspen dissolves, remains against big names
October 6, 2017Medical Communications, Sales and Marketing Genentech, Pfizer, Roche, aspen, biotech, drugs, pharma, pharmaceutical
South Africa’s Competition Commission has admitted that there is no case to be heard against Aspen and Equity, in regards …
Regulators get aggressive on matters excessive
June 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CMA, Drug pricing, European Commission, Pfizer, aspen
Gustaf Duhs, Partner at Stevens & Bolton, discusses the recent cases of regulators becoming firmer with drug companies over their …
European Commission targets Aspen over 1,500% price hikes
May 16, 2017Manufacturing and Production, Sales and Marketing European Commission, aspen
The European Commission (EC) has opened its first investigation over drug pricing following alleged hiking by pharma company Aspen, which …
Top Ten articles in the Pharma Industry this week
September 16, 2016Medical Communications Bayer, GSK, Gilead, GlaxoSmithKline, J&J, JJ, Pfizer, Roche, Sanofi, Takeda, aspen, google, monsanto
As we come to the end of another week, we’re looking back at an exciting week in the industry; there …
AstraZeneca sells rights to anaesthetics products to Aspen for $520 million upfront
June 9, 2016Research and Development, Sales and Marketing AstraZeneca, Licencing, anaesthetics, aspen, marketing agreement
UK drug firm AstraZeneca (LSE: AZN) on Thursday said it has agreed to sell rights for its anaesthetics portfolio to Aspen …
Pharma M&A trail continues as Pfizer buys slice of Dutch biotech
May 12, 2015Sales and Marketing Endo, Pfizer, aspen, merger
Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …
GSK sells off stake in Aspen for $853m
March 13, 2015Sales and Marketing Africa, China, GSK, Novartis, Singapore, aspen, merger, redfern
GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …
GSK sells off non-core assets
January 6, 2014Sales and Marketing GSK, Suntory, aspen, lucozade, ribena
GlaxoSmithKline has completed the offloading of several of its non-core assets in moves which stand to net the pharma manufacturer …
GSK makes £425 million Aspen sale
November 21, 2013Sales and Marketing GSK, Merck, South Africa, aspen
GlaxoSmithKline has raised £425 million with the sale of 28.2 million shares that it has in Africa’s biggest drugmaker as …
Aspen buys GSK plant and thrombosis drugs for $1.1 billion
October 1, 2013Manufacturing and Production, Sales and Marketing GSK, aspen
South African drugmaker Aspen Pharmacare has signed another combined brand and manufacturing facility deal, this time taking on GlaxoSmithKline’s thrombosis …
Aspen buys Merck facility and products in $1 billion deal
July 1, 2013Manufacturing and Production MSD, Merck, Oss, aspen
Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …
GSK mulling sales of thrombosis brands and facility to Aspen
June 24, 2013Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen
GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …
GSK receives thrombosis offer
June 19, 2013Sales and Marketing GSK, aspen, thrombosis
GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …
Latest content
Five Facts about cardiovascular disease
